High-dose-rate fractionated brachytherapy monotherapy for localized prostate cancer: a systematic review and meta-analysis

PURPOSE: High-dose-rate (HDR) brachytherapy as primary therapy (monotherapy) is a standard National Comprehensive Cancer Network (NCCN) endorsed treatment option for patients with localized prostate cancer. Thus far, most data are limited to single-institution experiences. Accordingly, we sought to...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Eric M., Kim, Sungjin, Sandler, Howard M., Kamrava, Mitchell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407258/
https://www.ncbi.nlm.nih.gov/pubmed/34484350
http://dx.doi.org/10.5114/jcb.2021.108590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407258/
https://www.ncbi.nlm.nih.gov/pubmed/34484350
http://dx.doi.org/10.5114/jcb.2021.108590

Ejemplares similares